Orthopaedics & Traumatology: Surgery & Research (2009) 95, 393—401
Pelvic chondrosarcomas: Surgical treatment options
X. Deloin∗, V. Dumaine, D. Biau, M. Karoubi,
A. Babinet, B. Tomeno, P. Anract
Orthopaedic and Traumatology Department A, Cochin Hospital, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France
Accepted: 12 May 2009
Introduction: Chondrosarcoma (CS) is a primary malignant bone tumor with cartilaginous dif-
ferentiation. The only available treatment is carcinological surgical resection since the usual
adjuvant treatments are ineffective. The pelvic location creates specific technical difficulties
both for exeresis and reconstruction. Our objective was to evaluate the carcinological and
functional outcomes of inter-ilioabdominal amputation and conservative surgery.
Materials and methods: We retrospectively studied 59 cases of pelvis chondrosarcoma managed
in our department between 1968 and 2003. Demographic, anatomopathological, surgical and
survival data were analyzed. Survival was estimated by the Kaplan-Meier curves and the cumu-
lative incidence method. Multivariate analysis was used to identify all possible independent
Results: There were 33 men and 26 women, with an average age of 48 years. The average
follow-up duration was 94 months. Eleven patients had a grade 1 chondrosarcoma, 36 a grade 2
chondrosarcoma, five were grade 3, and seven were dedifferentiated chondrosarcoma. Eleven
patients underwent an inter-ilioabdominal disarticulation, and 48 had a more conservative
surgery. Resection margins proved healthy in 46 patients (78%). Eighteen patients (31%) had
a local recurrence, and 12 (20%) had metastases. At last follow-up, 30 patients (51%) were
still alive without any sign of recurrence. Twenty-three patients (39%) died from the disease.
Multivariate analysis showed that margin invasion was associated with a definitely increased
local recurrence rate. A high tumoral grade was correlated with a greater risk of metastases
occurrence. These two last factors (margin status and tumor grade) as well as acetabulum
involvement were correlated with a reduced survival rate.
Function was better among patients treated by conservative surgery, and among them, even
better when the peri-acetabular area remained intact.
Our study confirmed that resection margins quality is a major prognostic factor both for local
control and for survival. On the other hand, local recurrence is an adverse survival prognosis
factor and is itself correlated with resection margins quality.
E-mail address: firstname.lastname@example.org (X. Deloin).
1877-0568/$ – see front matter © 2009 Elsevier Masson SAS. All rights reserved.
394X. Deloin et al.
Peri-acetabular chondrosarcoma location (in zone 2) appears to be a poor oncological prog-
nosis factor since, in this location, obtaining healthy margins appears particularly difficult.
Compared to resection, inter-ilioabdominal amputation did not prove its superiority concern-
ing resection margins quality or survival. However, resection guaranteed a better functional
Conclusion.— Chondrosarcoma of the pelvic girdle remains of worse prognosis than periph-
eral bones chondrosarcoma since the critical prognosis factor is the resection margins quality.
This location, and especially the peri-acetabular zone, poses difficult specific technical prob-
lems when conservative surgery is selected. Various imaging techniques should help better
envision tumor resection extent. Inter-ilioabdominal amputation should only be resorted to
in non-metastatic patients, when the tumor does not seem to be removable with sufficient
healthy margins guarantee, or when local conditions make it impossible to hope for a good
Level of Evidence.— Level IV; therapeutic retrospective study.
© 2009 Elsevier Masson SAS. All rights reserved.
Chondrosarcoma (CS) is a malignant skeletal tumor with
cartilaginous differentiation. In terms of incidence, it repre-
sents the second most frequent bone tumor in adults , and
is preferentially located in the pelvis in 22 to 39% of cases
[2—7]. CSs of the pelvic girdle remain asymptomatic in the
long-term and may thus be large at the time of diagnosis.
From a therapeutic viewpoint, CS is individualized
from other primary skeletal tumors as it is radioresistant
and chemoresistant: its only treatment is carcinological
surgical exeresis. However, depth in the pelvis, tumor
size and its connections with local articular, nervous,
vascular and visceral structures very often make carcinolog-
ical exeresis difficult and require complex reconstructions
The objective of this work is to evaluate the carcinolog-
ical and functional results of different surgical treatments
of CS of the pelvic girdle.
Materials and methods
We report data from a retrospective, monocentric study in
a series of 59 patients with CS of the pelvis and treated
surgically by the Orthopaedics Service of Cochin Hospital
between 1968 and 2003. Patients treated initially in another
establishment were not included.
In all cases, the diagnosis of CS was confirmed histolog-
ically by a referred pathologist specialized in the diagnosis
of tumors of the locomotor apparatus. The following clin-
ical data were analyzed: sex, age, initial clinical picture,
duration of symptoms at the time of diagnosis. Tumor loca-
tion was studied on radiographs as well as by scanner and
magnetic resonance imaging when they were available. The
topographical characteristics of the tumor were expressed
according to the Muskuloskeletal Tumor Society classifica-
tion [10,13]. Macroscopic data, i.e., tumor size defined by
its largest diameter, and microscopic findings, i.e. grade
according to O’Neal and Ackerman , were collected.
Resection margins were analyzed according to the classifi-
cation of Enneking et al. . Type of surgical intervention,
local recurrence, metastases, and patient outcome were
studied. Function was evaluated by walking, and pain graded
according to the 30-point score of the Musculoskeletal Tumor
Follow-up was calculated from the intervention data at
Cochin Hospital until the day of death or the last follow-
up. Survival was estimated by Kaplan-Meier curves and the
cumulated incidence method in the presence of events com-
peting with the event of interest.
Cox’s proportional model was used to estimate the effect
(hazard ratio or relationship of instant risks) of different
variables on the events considered. Multivariate analysis
served to identify a set of variables independently prognos-
tic of the events. The analyses were performed with the R
2.5.1 statistical analysis program; all tests were bilateral
and significant from a threshold of 0.05.
Thirty-three men and 26 women, with an average age of 48
years at the time of diagnosis (23 to 78 years) were managed
for CS of the pelvic girdle. Average follow-up was 94 months
(3—311 months). The patients were followed for a minimum
of four years or until their death.
Fifty-two patients had a biopsy before exeresis. In seven
cases, the histological diagnosis was confirmed by the study
of exeresis pieces without preliminary biopsy.
Forty-seven patients (80%) had a primary CS, and 12
(20%) had a secondary CS with a preexistent benign tumor
Grade 2 CSs were most frequent (n=36). This series had
seven dedifferentiated CS.
Fourteen patients (24%) had a zone 1 (iliac) tumor, includ-
ing four with sacral invasion; 42 patients (71%) had a zone
Pelvic chondrosarcomas: Surgical treatment options395
Epidemiological and histological characteristics of
Tumor grade 
2 (acetabular) lesion, and three patients (5%) had zone 3
The average duration of symptoms before the diagnosis was
14.5 months. Pain was the most frequent symptom (n=45).
Eight patients consulted because of palpable tumefaction.
The other patients consulted because of abnormal radiolog-
One patient had a pulmonary metastasis at the time of
Eleven inter-ilioabdominal disarticulations and 48 conser-
vative interventions were performed. In three cases of
dedifferentiated CS, chemotherapy was associated with
Zone 1 CS (n=14)
Eleven patients underwent partial or total resection of the
ilium. In two cases, exeresis included the sacrum. An ampu-
tation was undertaken because of major invasion of the
Zone 2 CS (n=42)
There were five isolated resections of the acetabulum.
Twenty patients had partial or total resection of the
acetabulum associated with partial or total resection of the
pubis or ischium.
Four partial or total resections of the acetabulum were
undertaken in association with all or part of the ilium.
Three patients had resection of the acetabulum, ilium
and ischium and/or the pubis.
Ten inter-ilioabdominal disarticulations were performed.
Zone 3CS (n=3)
All cases were treated by exeresis of all or part of the
ischium and the pubis.
They were considered to be healthy in 46 cases (78%),
marginal in two cases (3%) and contaminated in 11 cases
In the amputation group (n=11), the margins were
healthy in seven cases (63%), and contaminated in four cases
In the conservative treatment group (n=48), the margins
were healthy 39 times (81%), exeresis was marginal twice
(5%), and the margins were contaminated seven times (14%).
After resection of the iliac wing(n=13), reconstruction was
carried out in three cases, by autografts (n=2) or allografts
After resection of all or part of the acetabulum (n=32),
reconstruction was conducted according to the following
• total hip prostheses, n=10,with six Puget interventions
• saddle prostheses, n=8;
• arthrodesis, n=7, with three femoro-iliac arthrodesis,
three femoro-obturator arthrodesis and one femorocoty-
• bone reconstructions of the cotyle, n=4;
• neocotyles at the expense of the iliac wing, n=2.
In one case, no reconstruction was undertaken: resection
involved a non-weight-bearing zone of the posterior cotyle
No reconstructions were carried out after isolated resec-
tion of the pubis (n=3).
Reconstruction according to the Puget technique.
396 X. Deloin et al.
Thirty patients (51%) were alive without signs of recurrence
at last follow-up, with a survival average of 123 months (48
to 272 months).
Twenty-three patients (39%) died from the disease. Their
average survival was 69 months (3 to 312 months).
recurrence at the time of their death, within an average of
59 months (6 to 119 months).
Thus, the global survival rate was 90% (CI: 82—98%) at
one year, 66% (CI: 55—80%) at five years, 52% (CI: 39—70%)
at 10 years and 45% (CI: 32—64%) at 15 years (Fig. 2).
Multivariate analysis searched for risk factors of death.
This analysis showed that invasive resection margins
(p=0.00001, RR=7.28) (Fig. 3), high histological grade (3 or
dedifferentiated) (p=0.0005, RR=4.57) (Fig. 4), and tumors
invading the acetabulum (p=0.049, RR=3.24) were statisti-
cally pejorative factors for survival.
Eighteen patients (31%) had a local recurrence within an
average period of 37 months (5 to 230 months), associated
in four cases (22%) with one or more metastases at the time
of diagnosis (Table 2).
Among the 14 patients with a local recurrence without
metastasis at the time of diagnosis, three (21%) had sec-
ondary metastases within an average of 27 months after the
first recurrence (15 to 43 months).
Local recurrence was treated surgically in 12 cases: inter-
ilioabdominal disarticulation from diagnosis in one case,
intralesional exeresis surgery in 11 cases, multiple surgeries
ilioabdominal amputation afterwards. A patient with local
recurrence and synchronous adrenal metastasis received
chemotherapy (dedifferentiated CS).
studied event was patient death in relation to the disease.
Kaplan-Meier analysis of global patient survival. The
patient survival as a function of resection margin quality.
Comparison according to the Cox model of global
A patient with local recurrence and synchronous pul-
monary metastasis was treated by chemotherapy alone.
Five patients received no treatment.
All patients who had a local recurrence died within an
average time period of 38 months (0—240 months) after the
diagnosis of recurrence. Reoperated patients lived an aver-
age of 55 months (1—240 months), non-reoperated patients
lived an average of 3.5 months (0—6 months), but among
them, three had metastases at the time of local recurrence
patient survival as a function of histological tumor grade. Low
grade: grades 1 and 2; high grade: grade 3 and dedifferentiated
Comparison according to the Cox model of global
Pelvic chondrosarcomas: Surgical treatment options397
Characteristics of local recurrences.
Initial CS grade
Time period after initial intervention
Delayed diagnosis — death
Multivariate analysis objectively established that the risk
of local recurrence was strongly correlated with invasion of
the resection margins (p=0.001). The probability of local
recurrence at 10 years was 15% for patients with healthy
resection margins, and was 54% for patients whose margins
were contaminated (Fig. 5).
Characteristics of metastases.
Without local recurrence
With local recurrence
Initial CS grade
Delayed diagnosis — death
On the other hand, high histological grade (3 and ded-
ifferentiated) was not a risk factor for local recurrence
(p=0.3), just like tumor location (p=0.28) (Fig. 6).
Twelve patients (20%) developed metastases, associated
with local recurrence in seven cases (58%), synchronous in
four, or secondary in three (Table 3).
The average time of occurrence was 41 months (3 to
189 months). Metastases were most frequently localized in
the lungs (n=11), associated in two cases with liver metas-
tases. We observed a case of adrenal metastasis during the
evolution of dedifferentiated CS.
function of resection margin quality. a: event probability local recurrence metastases.
Analysis according to the cumulative incidence method of local recurrence risk (Fig. 5a) and metastasis (Fig. 5b) as a
398X. Deloin et al.
function of histological tumor grade. Low grade: grades 1 and 2; high grade: grade 3 and dedifferentiated CS.
Analysis according to the cumulative incidence method of local recurrence risk (Fig. 6a) and metastasis (Fig. 6b) as a
Metastases complicated the evolution of seven grade 2
CS (19% of grade 2 CS), one grade 3 CS (20%) and four ded-
ifferentiated CS (57%).
Two metastasectomies were performed: one pulmonary
metastasis and one adrenal metastasis, responsible for per-
operative patient death.
All patients died within an average time period of eight
months (1 to 55 months) after the diagnosis of metastasis.
Multivariate analysis showed that high histological grade
(3 or dedifferentiated) was correlated with a high risk of
metastasis (p=0.03) (Fig. 6). Tumor size and resection mar-
the occurrence of metastasis.
The average score obtained was 18 out of 30 (5 to 28).
In amputated patients (n=3), it was on average six
points. These patients received Canadian prostheses, and
one of them used it only inside his residence.
In patients treated by conservative surgery, the average
score was 20 (14 to 28). Patients whose resection did not
touch the acetabulum scored an average of 26 points (20 to
28), whereas those whose resection involved all or part of
the cotyle had an average score of 16 points (14 to 21).
Forty complications occurred and are regrouped in Table 4.
The main complications were infectious in the ampu-
tation group, and mechanical in the conservative surgery
In addition, three perioperative deaths occurred after
surgical revision for recurrences: a patient died during
exeresis of an adrenal metastasis 22 months after his ini-
tial conservative treatment for dedifferentiated CS. Another
patient died in the course of his fifth palliative revision
(intralesional tumorectomy), 122 months after his initial
intervention for a grade 2 CS. Finally, a patient died on
Day 10 of palliative surgical revision for massive recurrence,
seven months after inter-ilioabdominal disarticulation for a
massive grade 2 myxoid CS.
As observed, CSs are slightly male-predominant tumors,
which affect mature adults with peak frequency in the
fourth decade [2,3,5,7,17—20]. High-grade CS appears to be
predominant in men after 50 years , which we also noted
in our series.
In our series, 20% of CSs of the pelvic girdle occurred
on a benign bone tumor, with an incidence varying between
9 and 32%, and was comparable to that found at the level
Pelvic chondrosarcomas: Surgical treatment options399
of the limbs [6,17,20—29]. Whereas there was no prognostic
difference between primary and secondary CSs in our series,
Sheth et al.  reported a better prognosis for secondary
The only treatment of CS, whatever its location, is surgical
carcinological exeresis [3,5,6,17—19,23,24,30—40]. The sur-
vival of patients with CS of the pelvic girdle varies between
51% and 88% at 10 years [6,31,33,35,41]. It is lower than that
of patients with peripheral CS (57% to 83%) [6,37,42,43].
Block resection with healthy surgical margins makes
it possible to obtain the lowest rate of recurrence and
better survival [6,24,31,33,35,39]. The rate of healthy mar-
gins is very variable in the literature, ranging from 25 to
82% [5,24,31,33,35]. The wide variability of these data
is probably related to series inhomogeneity and operator
experience as well as the practical difficulty of histologi-
cally characterizing resection margins. Intralesional surgery
is a statistically significant risk factor for local recurrence
The two series in the literature assigned to intralesional
surgery of pelvic CS both concluded that this technique is
ineffective [34,40]. This is also true for grade 1 CS for which
it was originally proposed  and which concurs with our
observations. Twelve out of 13 patients (92%) with inade-
quate margins had recurrences, and the sole patient who did
not have recurrence died precociously (6 months) after his
surgery, from causes unrelated to his disease (cerebrovas-
Tumor location was also a significant prognostic factor.
Periacetabular location in our study was a statistically
significant risk factor pejorative for survival. This was also
the case for Mochizuki et al. . For Sheth et al. , zone
3 CS is a poor prognostic factor for survival, and for Ozaki et
al. , zone 3 location carries a greater risk of local recur-
rence, without the difference being statistically significant.
This is probably due to the surgical difficulty in obtaining
healthy margins in particular locations, unlike zone 1, which
is easily accessible, with the exception of cases of crossing
the sacroiliac articulation.
Taking these data into consideration, resection margin
quality seems to be a major prognostic factor as much for
the local control of CS as for patient survival.
In this pelvic location, local recurrences are frequent: their
incidence varies from 18 to 45% in the literature, and 31% in
our experience [6,17,21,24,31,33,35,42,43].
We have observed that the risk of local recurrence
is directly related to the quality of initially exere-
sis margins, which is corroborated by several studies
In our work, local recurrence constituted a poor prog-
nostic factor as it was statistically significantly associated
with decreased survival, as demonstrated by other authors
[5,31,33,35]. According to Fiorenza et al. , local recur-
rence affects survival in a pejorative manner when it is
associated with one or more synchronous metastases. Only
two studies have not provided evidence of the influence of
local recurrence on survival [6,24].
According to Pring et al. , high-grade CSs are signif-
icant risk factors for local recurrence. Our study does not
confirm these results.
Concerning treatment of local recurrence, we observed
that patients undergoing surgical exeresis showed better
survival than those who were not so treated, but the two
study populations were too small in size to provide proof of
a statistically significant difference.
Influence of surgical technique (amputation versus
conservative treatment) on resection margin
Our series did not find evidence of a statistically sig-
nificant difference between the two types of surgery to
obtain healthy margins (63% for the amputation group ver-
sus 81% for the conservative surgery group) or in terms
of survival. Many series arrived at the same conclusion
[7,24,35,36,44,45]. Although these studies, as in our own
experience, confirm the influence of surgical margins on
local recurrence, none of them demonstrated the supe-
riority of a technique in achieving healthy margins and
concluded that conservative treatment as soon as possible
should be preferred, to guarantee better functional results
for a similar survival rate.
Two studies have reported the superiority of amputa-
tion over conservative surgery. In 1972, Marcove et al. 
observed a statistically significant difference between inter-
ilioabdominal disarticulation and local resection for survival
criteria. In 2005, Donati et al.  showed, in a series of
125 pelvic CSs, that radical surgery made it possible to
obtain a higher level of healthy surgical margins (80% versus
61% for conservative surgery, p=0.077), and a diminution
of the local recurrence level. This result is at the limit of
significance. Moreover, these two studies have the same lim-
itations: the age of the records studied that is responsible
for insufficiency of preoperative radiological assessment.
It indeed appears logical that improvements in imaging
techniques provide good assessments of margin quality and
tumor resection before the intervention. According to the
same reasoning, the use of navigation may improve the qual-
ity of exeresis [46,47]. However, Fiorenza et al. , in a
series of 153 axial and peripheral CSs in 2002, did not man-
age to show that improved preoperative imaging associated
with radical surgery made it possible to improve resection
margins, the rate of local recurrence and survival.
It thus does not appear possible to conclude on the supe-
riority of amputation both in terms of resection margin
quality and survival. Our rare indications of first-intention
amputation to date remain bulky tumours with vascular or
nerve invasion, infected tumors or on radiation zones, in
As already reported in the literature [6,35,48,49], our series
logically confirms that patients treated by conservative
surgery have a higher functional score than those treated by
400 X. Deloin et al.
patients treated by first-intention conservative surgery, 92%
preserved their limb until the last follow-up. Studies pub-
lished in the last 10 years objectively quantified the limb
preservation level at the latest follow-up after initial con-
servative surgery, varying from 48 to 90% [6,24,33,35,41].
The large variability of these data is probably related to the
great heterogeneity of these series.
Among the reconstructions, the functional results were
worse than those concerning the acetabular zone. Zone
1 reconstructions only or isolated zone 3 resections with-
out reconstruction had a better functional prognosis. These
results conform with those reported in the literature
[13,35], acetabular reconstruction remaining the main dif-
ficulty of reconstructive pelvic surgery [9,11,13,48—53].
The survival of patients with CS of the pelvis is related to
local recurrence, initial tumor location and grade. The risk
of local recurrence is related to resection margin quality.
The main objective of surgical treatment must thus be to
obtain healthy resection margins, while preserving the limb
and its function as much as possible.
There is no proof that inter-ilioabdominal disarticulation
is superior to conservative surgery in terms of this objec-
tive and survival. On the other hand, conservative surgery
gives better functional results than amputation without poor
It is thereforenot advisable
ilioabdominal disarticulation when conservative surgery is
achievable. Preoperative imaging will allow us to better
appreciate lesion resection and the possibility of obtaining
The survival of patients treated for CS of the pelvic gir-
dle remains lower than those with peripheral locations as
it is more difficult to obtain healthy margins. The devel-
opment of adjuvant treatments is particularly expected to
limit the consequences of incorrect margins. Margin quality
could gain with the use of peroperative navigation systems.
Conflicts of interest
 Unni KK. Chondrosarcoma. In: Dahlin’s Bone Tumor. General
aspects and data on 11,087 cases, 5th ed. Lippincott-Raven:
Philadelphia, 1996; p. 71—108.
 Campanacci M. Bone, Soft Tissue Tumors. New York: Springer;
1986. p. 267—304.
 Henderson ED, Dahlin DC. Chondrosarcoma of bone—A study
of two hundred and eighty-eight cases. J Bone Joint Surg
 Huvos AG. In: Bone Tumors: Diagnosis, Treatment and Progno-
sis. WB Saunders: Philadelphia, 1979; p. 206—237.
 Lee FY, Mankin HJ, Fondren G, Gebhardt MC, Springfield DS,
Rosenberg AE, et al. Chondrosarcoma of bone: an assessment
of outcome. J Bone Joint Surg Am 1999;81(3):326—38.
 Ozaki T, Hillmann A, Lindner N, Blasius S, Winkelmann
W. Chondrosarcoma of the pelvis. Clin Orthop Relat Res
 Ucla E, Tomeno B, Forest M. Facteurs du pronostic tumoral dans
les chondrosarcomes de l’appareil locomoteur. Rev Chir Orthop
Reparatrice Appar Mot 1991;77(5):301—11.
 Aydinli U, Ozturk C, Yalcinkaya U, Tirelioglu O, Ersozlu S. Limb-
sparing surgery for primary malignant tumours of the pelvis.
Acta Orthop Belg 2004;70(5):417—22.
 Bell RS, Davis AM, Wunder JS, Buconjic T, McGoveran B, Gross
AE. Allograft reconstruction of the acetabulum after resection
of stage-IIB sarcoma. Intermediate-term results. J Bone Joint
Surg Am 1997;79(11):1663—74.
 Enneking W, Dunham W. Resection and reconstruction for pri-
mary neoplasm involving the innominate bone. J Bone Joint
Surg Am 1978;60(6):731—46.
 Frassica FJ, Chao EY, Sim FH. Special problems in limb-salvage
surgery. Semin Surg Oncol 1997;13(1):55—63.
 Gerrand CH, Bell RS, Griffin AM, Wunder JS. Instability after
major tumor resection: prevention and treatment. Orthop Clin
North Am 2001;32(4):697—710.
 O’Connor MI, Sim FH. Salvage of the limb in the treat-
ment of malignant pelvic tumors. J Bone Joint Surg Am
 O’Neal L, Ackerman L. Chondrosarcoma of bone. Cancer
 Enneking WF, Spanier SS, Goodman MA. A system for the
surgical staging of musculoskeletal sarcoma. Clin Orthop
 Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard
DJ. A system for the functional evaluation of reconstructive
procedures after surgical treatment of tumors of the muscu-
loskeletal system. Clin Orthop Relat Res 1993;286:241—6.
 Gitellis S, Bertoni F, Campanacci M. Chondrosarcoma of bone.
The experience at Instituto Orthopedico Rizzoli. J Bone Joint
 Healey JH, Lane JM. Chondrosarcoma. Clin Orthop Relat Res
 Marcove RC. Chodrosarcoma: diagnosis and treatment. Orthop
Clin North Am 1977;8(4):811—20.
 Dahlin DC, Unni KK. Bone Tumors. General aspect and data
on 8522 cases. In: Thomas CC, editor. Springfield, 1986.
 Evans HL, Ayala AG, Romsdahl MM. Prognostic factor in chon-
drosarcoma of bone: a clinicopathologic analysis with emphasis
on histologic grading. Cancer 1977;40:818—31.
 Dahlin DC, Henderson ED, Chondrosarcoma. a surgical and
pathological problem: review of 212 cases. J Bone Joint Surg
 Kawai A, Healey JH, Boland PJ, Lin PP, Huvos AG, Meyers PA.
Prognostic factors for patients with sarcomas of the pelvic
bones. Cancer 1998;82(5):851—9.
 Sheth DS, Yasko AW, Johnson ME, Ayala AG, Murray JA,
Romsdahl MM. Chondrosarcoma of the pelvis. Prognostic fac-
tors for 67 patients treated with definitive surgery. Cancer
 Forest M, Tomeno B, Vanel D. In: Orthopedic Surgical Pathology:
Diagnosis of Tumors and Pseudotumoral Lesions of Bone and
Joint. Churchill-Livingstone: Edinburgh, 1998; p. 27—32.
 Marcove RC, Mike V, Hutter RV, Huvos AG, Shoji H, Miller TR, et
al. Chondrosarcoma of the pelvis and upper end of the femur.
An analysis of factors influencing survival time in one hundred
and thirteen cases. J Bone Joint Surg Am 1972;54(3):561—72.
 Pritchard DJ, Lunke RJ, Taylor WF, Dahlin DC, Medley BE. Chon-
 Sanerkin NG, Gallagher P. A review of the behaviour of
chondrosarcoma of bone. J Bone Joint Surg Br 1979;61-
 Schaison F, Anract P, Coste F, De Pinieux G, Forest M, Tomeno
Pelvic chondrosarcomas: Surgical treatment options401
multiples. Étude de 29 cas cliniques et revue de la littérature.
Rev Chir Orthop Reparatrice Appar Mot 1999;85(8):834—45.
 Ball AB, Barr L, Westbury G. Chondrosarcoma of the pelvis:
the role of palliative debulking surgery. Eur J Surg Oncol
 Bergh P, Gunterberg B, Meis-Kindblom JM, Kindblom LG. Prog-
nostic factors and outcome of pelvic, sacral, and spinal
chondrosarcomas: a center-based study of 69 cases. Cancer
 Bruns J, Fiedler W, Werner M, Delling G. Dedifferentiated
chondrosarcoma—a fatal disease. J Cancer Res Clin Oncol
 Donati D, El Ghoneimy A, Bertoni F, Di Bella C, Mercuri M.
Surgical treatment and outcome of conventional pelvic chon-
drosarcoma. J Bone Joint Surg Br 2005;87(11):1527—30.
 Ozaki T, Lindner N, Hillmann A, Rodl R, Blasius S, Winkelmann
W. Influence of intralesional surgery on treatment outcome of
chondrosarcoma. Cancer 1996;77(7):1292—7.
 Pring ME, Weber KL, Unni KK, Sim FH. Chondrosarcoma of the
pelvis. A review of sixty-four cases. J Bone Joint Surg Am
 Shin KH, Rougraff BT, Simon MA. Oncologic outcomes of pri-
mary bone sarcomas of the pelvis. Clin Orthop Relat Res
 Soderstrom M, Ekfors TO, Bohling TO, Teppo LH, Vuorio EI, Aro
HT. No improvement in the overall survival of 194 patients with
chondrosarcoma in Finland in 1971—1990. Acta Orthop Scand
 Terek RM, Schwartz GK, Devaney K, Glantz L, Mak S, Healey JH,
et al. Chemotherapy and P-glycoprotein expression in chon-
drosarcoma. J Orthop Res 1998;16(5):585—90.
 Weber KL, Pring ME, Sim FH. Treatment and outcome of
recurrent pelvic chondrosarcoma. Clin Orthop Relat Res
 Normand AN, Cannon CP, Lewis VO, Lin PP, Yasko AW. Curettage
of biopsy-diagnosed grade 1 periacetabular chondrosarcoma.
Clin Orthop Relat Res 2007;459:146—9.
 Mochizuki K, Yamaguchi H, Umeda T. The management of pelvic
chondrosarcoma in Japan. Japanese Musculo-Skeletal Oncology
Group. Int Orthop 2000;24(2):65—70.
 Bjornsson J, McLeod RA, Unni KK, Ilstrup DM, Pritchard DJ. Pri-
mary chondrosarcoma of long bones and limb girdles. Cancer
 Fiorenza F, Abudu A, Grimer RJ, Carter SR, Tillman RM,
Ayoub K, et al. Risk factors for survival and local control in
chondrosarcoma of bone. J Bone Joint Surg Br 2002;84(1):
 Springfield DS, Gebhardt MC, McGuire M. Chondrosarcoma: a
review. J Bone Joint Surg Am 1996;78(1):141—9.
 Dickey ID, Rose PS, Fuchs B, Wold LE, Okuno SH, Sim FH, et al.
Dedifferentiated chondrosarcoma: the role of chemotherapy
with updated outcomes. J Bone Joint Surg Am 2004;86-
 Krettek C, Geerling J, Bastian L, Citak M, Rücker F, Kendoff
D, et al. Computer aided tumor resection in the pelvis. Injury
 Hufner T, Kfuri Jr M, Galanski M, Bastian L, Loss M, Pohle-
mann T, et al. New indications for computer-assisted surgery:
tumor resection in the pelvis. Clin Orthop Relat Res 2004;426:
 Hugate Jr R, Sim FH. Pelvic reconstruction techniques. Orthop
Clin North Am 2006;37(1):85—97.
 Hoffmann C, Gosheger G, Gebert C, Jurgens H, Winkelmann
W. Functional results and quality of life after treatment of
pelvic sarcomas involving the acetabulum. J Bone Joint Surg
 Aboulafia AJ, Buch R, Mathews J, Li W, Malawer MM. Recon-
struction using the saddle prosthesis following excision of
primary and metastatic periacetabular tumors. Clin Orthop
Relat Res 1995;314:203—13.
 Harrington KD. The use of hemipelvic allografts or autoclaved
grafts for reconstruction after wide resections of malignant
tumors of the pelvis. J Bone Joint Surg Am 1992;74(3):331—41.
 Marco RA, Sheth DS, Boland PJ, Wunder JS, Siegel JA, Healey
JH. Functional and oncological outcome of acetabular recon-
struction for the treatment of metastatic disease. J Bone Joint
Surg Am 2000;82(5):642—51.
 Satcher Jr RL, O’Donnell RJ, Johnston JO. Reconstruction of
the pelvis after resection of tumors about the acetabulum. Clin
Orthop Relat Res 2003;409:209—17.